Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole add-on treatment for treatment-resistant depression
ISRCTN84666271Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Aug 2020
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in treatment-resistant depression (TRD) and major depressive disorder (MDD) comparing Pramipexole add-on with Placebo add-on (2 arms). Primary endpoint: Primary efficacy. Started Aug 2020; status: completed.
02
Drugs
pramipexole
03
Conditions
treatment-resistant depression (TRD)major depressive disorder (MDD)
Beyond the preview
Go deeper on ISRCTN84666271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN84666271.